Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Paolo Corradini

How Many Chronic Myeloid Leukemia Patients Who Started a Frontline Second‐generation Tyrosine Kinase Inhibitor Have to Switch to a Second‐line Treatment? A Retrospective Analysis From the Monitoring Registries of the Italian Medicines Agency (AIFA)

Cancer Medicine

English

The Role of Autologous and Allogeneic Stem Cell Transplantation in Follicular Lymphoma in the New Drugs Era.

Mediterranean Journal of Hematology and Infectious Diseases

Infectious Diseases

Hematology

2016

English

Related publications

Use of Second Generation Tyrosine Kinase Inhibitors for Second-Line Treatment of Chronic Myeloid Leukemia After Imatinib Failure

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi

Oncology

Hematology

2011

English

Arterial Events in Patients With Chronic Myeloid Leukemia Receiving Treatment With Second Generation Tyrosine Kinase Inhibitors

Klinicheskaya Onkogematologiya/Clinical Oncohematology

Oncology

Hematology

2016

English

The Management of Chronic Myeloid Leukemia in the Era of Second Generation Tyrosine Kinase Inhibitors

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi

Oncology

Hematology

2016

English

Managing Chronic Myeloid Leukemia Patients Intolerant to Tyrosine Kinase Inhibitor Therapy

English

Use of Second- And Third-Generation Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia: An Evolving Treatment Paradigm

Clinical Lymphoma, Myeloma and Leukemia

English

Tyrosine Kinase Inhibitor Sequencing in Patients With Chronic Myeloid Leukemia

Oncology and Therapy

Oncology

2019

English

Long-Term Outcomes in the Second-Line Treatment of Chronic Myeloid Leukemia

English

Discovering Gene Expression Signatures Responding to Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia

BMC Medical Genomics

Genetics

2016

English

Thyroid Dysfunction Caused by Second-Generation Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Paolo Corradini

How Many Chronic Myeloid Leukemia Patients Who Started a Frontline Second‐generation Tyrosine Kinase Inhibitor Have to Switch to a Second‐line Treatment? A Retrospective Analysis From the Monitoring Registries of the Italian Medicines Agency (AIFA)

The Role of Autologous and Allogeneic Stem Cell Transplantation in Follicular Lymphoma in the New Drugs Era.

Related publications

Use of Second Generation Tyrosine Kinase Inhibitors for Second-Line Treatment of Chronic Myeloid Leukemia After Imatinib Failure

Arterial Events in Patients With Chronic Myeloid Leukemia Receiving Treatment With Second Generation Tyrosine Kinase Inhibitors

The Management of Chronic Myeloid Leukemia in the Era of Second Generation Tyrosine Kinase Inhibitors

Managing Chronic Myeloid Leukemia Patients Intolerant to Tyrosine Kinase Inhibitor Therapy

Use of Second- And Third-Generation Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia: An Evolving Treatment Paradigm

Tyrosine Kinase Inhibitor Sequencing in Patients With Chronic Myeloid Leukemia

Long-Term Outcomes in the Second-Line Treatment of Chronic Myeloid Leukemia

Discovering Gene Expression Signatures Responding to Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia

Thyroid Dysfunction Caused by Second-Generation Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia